azathioprine has been researched along with Fatigue in 10 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Fatigue: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pancytopenia was most likely azathioprine-related." | 3.74 | [Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease]. ( Günther, U; Loddenkemper, C; Preiss, JC; Schumann, M; Siegmund, B; Somasundaram, R; Zeitz, M, 2008) |
| "Treatment with azathioprine may - depending on its cumulative dosage - lead to pancytopenia and subsequent development of myelodysplasia or secondary leukaemia, respectively." | 3.72 | [Azathioprine-associated myelodysplastic syndrome with cytogenetic aberrations]. ( Kaiser, U; Schlegelberger, B; Wilkens, L; Willerding-Möllmann, S, 2004) |
| " Indications for switch, dosing and subsequent clinical outcomes (including thiopurine persistence) were recorded." | 1.48 | Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease. ( Beswick, L; Friedman, AB; Haridy, J; Moltzen, A; Raghunath, A; Sparrow, M; van Langenberg, D; Vasudevan, A, 2018) |
| "Fatigue is a frequent symptom of patients with sarcoidosis." | 1.40 | Factors associated with fatigue in sarcoidosis. ( Bosse-Henck, A; Brähler, E; Fleischer, M; Hinz, A; Wirtz, H, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bozzalla Cassione, E | 1 |
| Zanframundo, G | 1 |
| Biglia, A | 1 |
| Codullo, V | 1 |
| Montecucco, C | 1 |
| Cavagna, L | 1 |
| Vasudevan, A | 1 |
| Beswick, L | 1 |
| Friedman, AB | 1 |
| Moltzen, A | 1 |
| Haridy, J | 1 |
| Raghunath, A | 1 |
| Sparrow, M | 1 |
| van Langenberg, D | 1 |
| Fleischer, M | 1 |
| Hinz, A | 1 |
| Brähler, E | 1 |
| Wirtz, H | 1 |
| Bosse-Henck, A | 1 |
| Schumann, M | 1 |
| Preiss, JC | 1 |
| Loddenkemper, C | 1 |
| Günther, U | 1 |
| Somasundaram, R | 1 |
| Siegmund, B | 1 |
| Zeitz, M | 1 |
| Seinen, ML | 1 |
| van Asseldonk, DP | 1 |
| de Boer, NK | 1 |
| Losekoot, N | 1 |
| Smid, K | 1 |
| Mulder, CJ | 1 |
| Bouma, G | 1 |
| Peters, GJ | 1 |
| van Bodegraven, AA | 1 |
| Tack, DK | 1 |
| Paisansinsup, T | 1 |
| Amin, S | 1 |
| Willerding-Möllmann, S | 1 |
| Wilkens, L | 1 |
| Schlegelberger, B | 1 |
| Kaiser, U | 1 |
| Gause, A | 1 |
| Inderrieden, DC | 1 |
| Laas, R | 1 |
| Arlt, AC | 1 |
| Gross, WL | 1 |
| Roenigk, HH | 1 |
| Deodhar, S | 1 |
| Kämpfen, P | 1 |
| Hodler, J | 1 |
10 other studies available for azathioprine and Fatigue
| Article | Year |
|---|---|
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Labora | 2020 |
Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Allopurinol; Australia; Azathioprine; Chemical and Drug Induced Liver Injur | 2018 |
Factors associated with fatigue in sarcoidosis.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cohort Studies; Fatigue; Female; Germany; Humans; Hyp | 2014 |
[Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease].
Topics: Ascites; Azathioprine; Blood Cell Count; Crohn Disease; Diagnosis, Differential; Fatigue; Focal Nodu | 2008 |
The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: results from a prospective pharmacological study.
Topics: Adult; Allopurinol; Azathioprine; Drug Therapy, Combination; Enzyme Activation; Enzyme Inhibitors; F | 2013 |
44-year-old woman with fatigue and dyspnea.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Dyspnea; Fatigue; Female; Humans; Immunosuppressive A | 2003 |
[Azathioprine-associated myelodysplastic syndrome with cytogenetic aberrations].
Topics: Anemia; Azathioprine; Bone Marrow; Bone Marrow Examination; Chromosome Aberrations; Chromosomes, Hum | 2004 |
Common variable immunodeficiency (CVID) and inclusion body myositis (IBM).
Topics: Adult; Arthralgia; Azathioprine; Common Variable Immunodeficiency; Fatigue; gamma-Globulins; Humans; | 2000 |
Pemphigus treatment with azathioprine. Clinical and immunologic correlation.
Topics: Adult; Aged; Antibodies; Azathioprine; Blood Platelets; Dose-Response Relationship, Drug; Fatigue; F | 1973 |
[Treatment of chronic glomerulonephritis with imuran].
Topics: Adolescent; Adult; Aged; Azathioprine; Biopsy; Blood Sedimentation; Child; Chronic Disease; Colic; D | 1970 |